Arcturus Therapeutics Holdings Inc is a biotechnology company focused on the development of transformative RNA medicines
The company utilizes its proprietary platform to create innovative therapies targeting various diseases, including infectious diseases and genetic disorders. By leveraging advanced technologies, such as self-amplifying mRNA and lipid nanoparticle delivery systems, Arcturus aims to improve the efficacy and safety of vaccines and therapeutics. Their pipeline includes candidates designed for both human and veterinary applications, reflecting their commitment to addressing significant unmet medical needs and enhancing patient outcomes.
CSL and Arcturus Therapeutics report that their sa-mRNA COVID-19 vaccine, ARCT-154, delivered superior immunogenicity compared to Pfizer's Comirnaty in a Phase 3 study, persisting for one year and at a lower dose.
Ark Invest, led by Cathie Wood, made significant trades on Wednesday involving Robinhood Markets Inc (NASDAQHOOD) and Zoom Video Communications Inc NASDAQ:ZMNASDAQZM)
On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQHOOD). This decision came amidst a period of market fluctuations and followed a recent trend of the investment firm adjusting its portfolio.
Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, showing FEV1 improvements and safety .
